Nicotinamide mononucleotide derivatives and their uses
US11878027B2 · kind B2 · utility
1Cited by
26References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2022 |
| Grant date | Jan 23, 2024 |
| Priority date | — |
| Expiry date | Jul 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.